#ExpertAnswers: Mirka Allerding and Anna Sophie Skof on Indivumed Services’ Cell-Free Plasma Biobank
Experts from Indivumed Services answer questions from webinar where they describe the role of longitudinal plasma samples for cancer research.
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
In this Q&A Report, experts discuss isolation methods, sample selection, testing techniques, and future applications of cell-free plasma samples for cancer diagnostics and treatment
Longitudinal Plasma Samples: Paving the Way for Precision Oncology
Experts present a cell-free plasma biobank and describe the role of longitudinal plasma samples for cancer research, disease monitoring, and biomarker development.
Brain-Derived Tau in Blood: the Future of Alzheimer’s Disease Diagnosis?
Recently published in Brain, Gonzalez-Ortiz et al. report the design and development of a novel blood-based biomarker specific to brain-derived tau. In this blog post, we dive into the advantages of their novel immunoassay over those that are commercially available, as well as its future implications for Alzheimer’s disease diagnosis.
#ExpertAnswers: Anuj Kalsy and Robert Snyder On The Variant-Rich Biobank
Anuj Kalsy and Robert Snyder showcase Precision for Medicine's variant-rich biobank, including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
The Variant-Rich Biobank: An Insider’s Look
Experts provide a showcase of Precision for Medicine's variant-rich biobank. including discussion on biospecimen types, applications, screening methods, and support for companion diagnostic development.
